• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 22-Aug-2019, 10:43 AM
SENSEX
36,804.39
-255.98 (-0.69%)
NIFTY
10,832.50
-86.20 (-0.79%)
    No Companies Visited

Back to news list
  • Sun Pharma sails through the tide after strong Q1 results

    Drug maker Sun Pharmaceuticals Industries rose 3.71% to end at Rs 437.55 on BSE after consolidated net profit rose 31.22% to Rs 1387.48 crore on a 15.69% rise in net sales to Rs 8,259 crore in Q1 June 2019 compared with Q1 June 2018.



    The result was announced during the market hours today, 13 August 2019.

    Meanwhile, the S&P BSE Sensex tanked 623.75 points or 1.66% and closed at 36,958.16.

    On the BSE, 9.04 lakh shares were traded in the counter so far compared with average daily volumes of 2.91 lakh shares in the past two weeks. The stock hit a high of Rs 444.8 and a low of Rs 420.8 so far during the day. The stock hit a 52-week high of Rs 678.8 on 06 Sep 2018. The stock hit a 52-week low of Rs 350.4 on 13 May 2019.

    The company's earnings before interest tax depreciation and amortization (EBITDA) stood at Rs 1881 crore with an EBITDA margin of 22.8% in Q1 June 2019.

    The company's R&D investments stood at Rs 422 crores (5.1% of sales) in Q1 June 2019 as compared to Rs. 500 crores (7% of sales) in Q1 June 2018.

    Commenting on company's Q1 performance, Dilip Shanghvi, managing director of the company said, “We have recorded growth across most of the markets for the quarter and our performance is in-line with our full-year guidance. We are consistently focusing on improving our efficiencies and cost structure to ensure reasonable returns for our generics business. At the same time, we continue our unwavering efforts on building the specialty business and are encouraged by the potential of one of our pre-clinical research molecules which is likely to enter clinical trials next year.

    Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company

    Back to news list
Previous Stories :
More
Hot Pursuit News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine Print Edition queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 22-Aug-2019
  •  ( 10:34) Shares extend early losses  
  •  ( 08:35) Most Asian stocks trading higher  
  •  ( 08:18) Infosys Expands Strategic Partnership with Google Cloud  
Show News
22 August 2019 10:47
1577.00
(-0.78 %)
664.00
(-0.15 %)
2743.50
(-0.74 %)
3211.00
(-1.53 %)
354.60
(-0.01 %)
2043.65
(-1.10 %)
1063.80
(-0.74 %)
2202.80
(-1.04 %)
2682.95
(-1.15 %)
1870.50
(1.11 %)
407.70
(-1.09 %)
1341.20
(-1.81 %)
796.70
(-0.36 %)
244.30
(1.12 %)
1486.35
(-1.29 %)
1300.20
(-0.77 %)
514.70
(-1.13 %)
6214.85
(-0.13 %)
116.70
(-1.06 %)
118.40
(-2.27 %)
201.85
(-1.44 %)
1261.75
(-0.71 %)
275.95
(-0.52 %)
413.95
(-0.80 %)
110.45
(-1.65 %)
52.05
(-1.51 %)
341.50
(-0.45 %)
2194.45
(0.39 %)
673.55
(0.16 %)
135.85
(-2.89 %)
61.90
(-5.35 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.